StocksFin Logo
Exelixis, Inc. country of incorporation
|
|
Dr. Michael Morrissey
|
954 employees
NASDAQ | Healthcare | Biotechnology
Sotera Health Company country of incorporation
|
|
3,000 employees
NASDAQ | Healthcare | Diagnostics & Research
Q322 reported Nov 1, 2022 Reporting Period
$411.74M 25.4% vs. Q321 Revenues Q322
96.28% -0.1% vs. Q321 Gross Profit Margin
17.78% 52.9% vs. Q321 Net Profit Margin
102.03M 22.5% vs. Q321 Free Cash Flow Q322
$0.23 91.7% vs. Q321 EPS Q322
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q322
Q322
Q322 reported Nov 2, 2022 Reporting Period
$248.7M 10% vs. Q321 Revenues Q322
54.69% -1.5% vs. Q321 Gross Profit Margin
10.09% -16.9% vs. Q321 Net Profit Margin
28.78M -64.4% vs. Q321 Free Cash Flow Q322
$0.09 -10% vs. Q321 EPS Q322
-
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q322
Q322
Loading...
Loading...
Loading...
Loading...
Ratios
As of
Dec 30, 2022
Sep 30, 2022
Quick Ratio
4.7
2.35
Current Ratio
4.99
3
Cash Ratio
1.55
1.17
Price to Book
2.26
3.15
Price to Sales
3.49
7.68
Price to Earnings
30.82
19.04